About Bionano
Bionano is a publicly listed company based in San Diego (United States) founded in 2002. Provider of genome analysis solutions to researchers and clinicians. It operates in the Healthcare and Technology sectors. Bionano has raised $124.2 million across 27 funding rounds from investors including NIH, HHS and National Cancer Institute. The company has 100 employees. Bionano has completed 1 acquisition, including BioDiscovery. Its chief executive, as recorded, is Erik Holmlin. Its website bionano.com draws about 17 thousand monthly visits. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Instrument Systems. Its competitors include PacBio, Omniome and Complete Genomics; 3 of its 3 listed competitors have raised funding.
Company details
Founded in 2002 and based in San Diego, United States, Bionano operates in the biotechnology sector, focusing on genome analysis tools. The Saphyr system is utilized for non-sequencing optical mapping of long genomic DNA strands. This technology is applied to identify structural variants overlooked by next-generation sequencing and traditional cytogenetic methods, supporting research and clinical applications.
- Headquarters San Diego, United States
- Employees 100
- Stage Public
- SectorsHealthcareTechnology
- Email••••••••
- Website bionano.com
- Social LinkedIn X Instagram
- Legal Name Bionano Genomics, Inc.
- Annual Revenue$28.51 M (USD)-7.37as on Dec 31, 2025
- Net Profit-$26.39 M (USD)76.44as on Dec 31, 2025
- EBITDA-$23.61 M (USD)66.97as on Dec 31, 2025
- Total Equity Funding$124.2M (USD)
in 27 rounds
- Latest Funding Round$20M (USD), Post-IPO
May 2024
- InvestorsNIH
& 15 more
- Employee Count100
- Investments & Acquisitions
Funding Insights of Bionano
Bionano has successfully raised a total of $124.2M across 27 strategic funding rounds. The most recent funding activity was a Post-IPO round of $20 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $124.2M
- Total Rounds 27
- Last Round Post-IPO — $20M
- Investors Count 16
Latest 10 of 27 funding rounds of Bionano with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2024 | $20M | Post-IPO | – | – | – |
| Mar 2019 | $2.5M | Post-IPO | – | – | – |
| Dec 2014 | $68.44M | Series C | – | Legend Capital, Novartis Venture Fund | |
| Jun 2014 | $5M | Series B | – | – | – |
| Sep 2013 | $10M | Series B | – | Domain Associates, Battelle Ventures | |
| Jun 2012 | $11.57M | Series B | – | – | – |
| Jun 2012 | $8.79M | Grant | – | – | |
| Mar 2011 | $23.3M | Series B | – | Domain Associates, Battelle Ventures | – |
| Apr 2010 | $782,314 | Series A | – | – | – |
| Oct 2009 | $833,490 | Grant | – | – |
16 investors in total: 16 institutional.
Investors in Bionano
Bionano has secured backing from 16 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH, HHS and National Cancer Institute.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture Capital firm focused on multiple sectors | legendcapital.com.cn | Haidian, China | ||
Investments are made in innovative life science companies globally. | nvfund.com | Basel, Switzerland | ||
| battelleventures.com | ||||
Life science & tech focused VC firm investing in the US | domainvc.com | Princeton, United States | ||
Offline focused VC firm funding companies in the US | ktventuregroup.com | San Jose, United States | ||
Investment and support are provided for Pennsylvania's tech-based companies. | 1983 | benfranklin.org | State College, United States | |
Technology ecosystem growth is supported in Southeastern Pennsylvania. | sep.benfranklin.org | Philadelphia, United States | ||
Diversified investment management services are provided to clients. | 2011 | monasheecap.com | Boston, United States | |
Genomics research and educational resources are provided. | 1988 | genome.gov | Bethesda, United States |
Investor details for Bionano
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Bionano
32 people are tracked at Bionano (15 in leadership, 17 in team); the tracked headcount is 100.
| Name | Role | Group |
|---|---|---|
Erik Holmlin | CEO | Leadership |
Melissa Bjork | Associate Director, Logistics And Distribution At Bionano | Leadership |
Spencer Baker | Associate Director, Supply Chain | Leadership |
Helene Klein | Chief People Officer | Leadership |
Sandrine Henry | Associate Director People & Culture EMEA-APAC | Leadership |
Mark Oldakowski | Chief Operating Officer | Leadership |
Cory Kreeck | Global Head of People Operations | Leadership |
Alka Chaubey | Chief Medical Officer | Leadership |
April Labrador | Associate Director, People and Culture | Leadership |
Ralph Hanna | Senior Director, Supply Chain | Leadership |
Cyprien Dulac | Associate Director Of Sales And Regional Business Leader, EMEA | Leadership |
Jaime L. Bennett, CPA, MSA | Director, SEC Reporting & Technical Accounting | Leadership |
Sean Paolino | Vice President of Finance | Leadership |
Jennifer Carlsen | Sr. Director Global Commercial Operations & Regional Business Lead | Leadership |
Gabriel Armstrong | Director Customer Solutions | Leadership |
Denise Finnerty | Commercial Operations Associate | Team |
Taylor Daly King | Talent Acquisition Consultant | Team |
Yvonne Mountain | Trade Show And Events Specialist | Team |
Julie Choy | Senior Accountant | Team |
Jonathan Dixon | General Counsel & Corporate Secretary | Team |
12 more people are available in the full profile.
Complete people profiles for Bionano
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Bionano
Bionano is a publicly listed company on the NASDAQ with ticker symbol BNGO in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date29 Jan 2021
- Listed onBMV: BNGO
- Listed entityBionano Genomics, Inc.
- Exchange sectorHealth technology
- ISINUS09075F4046
- Share price$1.36 (+1.12% on the day) · 2026-10-13
- Market capitalisation$16.0M
- EPS (diluted, trailing year)$-3.73
- Volume (last session)187,151
Financials of Bionano
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $28.5M | -$26.4M | -$23.6M |
| 2024 | $30.8M | -$112.0M | -$71.5M |
| 2023 | $36.1M | -$232.5M | -$125.7M |
| 2022 | $27.8M | -$132.6M | -$119.5M |
| 2021 | $18.0M | -$72.4M | -$73.1M |
Detailed financial statements for Bionano
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bionano
Bionano has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include BioDiscovery.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Software solutions for microarray and next-generation sequencing analysis are provided. | biodiscovery.com | El Segundo, United States | 1997 | Oct 2021 | $100M |
Complete acquisition details for Bionano
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Bionano
5 dated milestones of Bionano across 22 years, from founding to its latest funding, stage changes and deals.
- Founded Bionano is founded.
- Funding First funding round.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires BioDiscovery.
- Funding Latest funding round, Post-IPO, of $20.0M.
Competitors of Bionano
Bionano has 3 listed competitors in our database, 3 of them funded. They include PacBio, Omniome and Complete Genomics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pacb.com | 2004 | Menlo Park, United States | $395M | 649 | Instrument systems and software for single-molecule real-time sequencing are developed. | |
| omniome.com | 2013 | San Diego, United States | $160.23M | 164 | Genome sequencing platform is provided for clinical diagnostics. | |
| completegenomics.com | 2006 | San Jose, United States | $124.99M | 70 | DNA sequencing platform for human genome analysis is developed. |
Detailed competitors of Bionano
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Bionano
The website of Bionano (bionano.com) receives about 16.9K visits a month.
- Monthly visits16.9K
▲ 6.5% vs previous month
Websites whose visitors overlap most with Bionano. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
webull.co.jp | webull.co.jp | 100% | #394,854 | – | |
| partnersgroup.com | 100% | 155.9K | #299,714 | View details | |
| siliconvalleyjournals.com | 60% | #3,679,196 | View details | ||
| rosalind.bio | 35% | 9.1K | #2,228,840 | View details | |
invivoscribe.com | invivoscribe.com | 34% | #2,713,213 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for Bionano
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Bionano (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bionano
Complete news archive for Bionano
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bionano
Bionano was founded in 2002 and raised its 1st funding round 3 years after it was founded.
Bionano is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Erik Holmlin is the CEO of Bionano, as recorded in our data.
Bionano is a funded company, having raised a total of $124.2M across 27 funding rounds to date. The company's 1st funding round was a Grant of $833.49K, raised on Jun 2005.
Bionano has 100 employees.
Annual revenue of Bionano is $28.51M as on Dec 31, 2025.
Founded in 2002 and based in San Diego, United States, Bionano operates in the biotechnology sector, focusing on genome analysis tools. The Saphyr system is utilized for non-sequencing optical mapping of long genomic DNA strands. This technology is applied to identify structural variants overlooked by next-generation sequencing and traditional cytogenetic methods, supporting research and clinical applications.
Bionano's top competitors include PacBio, Complete Genomics and Omniome.
Yes, Bionano is publicly traded on NASDAQ under the ticker symbol BNGO.
Bionano has made 1 acquisition, including BioDiscovery.
Bionano has 16 investors. Key investors include NIH, HHS, National Cancer Institute, Ben Franklin Technology Partners, and NHGRI.